PCM
EFTR

Penserra Capital Management’s eFFECTOR Therapeutics, Inc. Common Stock EFTR Stock Holding History

Penserra Capital Management’s Portfolio EFTR Stock Details EFTR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-204
Closed -$7K – 1276
2022
Q2 		$7K Buy
204
+59
+41% +$2.03K ﹤0.01% 1327
2022
Q1 		$14K Buy
145
+25
+21% +$2.41K ﹤0.01% 1358
2021
Q4 		$24K Buy
+120
New +$24K ﹤0.01% 1217